In one paragraphArticle in The Journal of experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
24 authors.
Mara Cetty SpinellaInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-2363-3295 Francesco Gualdrini *Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-6180-7292 Cristina Leoni *Institute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-4458-1121 Jun Siong Low *Institute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-1775-0778 Sara Polletti *Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-5433-0502 Amy KenyonDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0001-9248-576X Samuele MauriInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0009-0009-0488-3107 Veronica VallelongaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0009-0004-2285-2711 Mehrpouya MostanfarInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0003-2624-7063 Matteo PecoraroInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0009-0002-8105-9671 Chiara SorianiDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-4363-6597 Roberta MarziInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-3501-4168 Fabio BedinDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0009-0006-4313-7762 Elena FoliInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0009-0003-3916-1653 Niccolò BianchiInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0001-5605-3425 Emina DžafoInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0001-8276-858X Sandra JovicInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0001-6871-8690 Alessandro CuomoDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-9778-7190 Simona RodighieroDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-4236-7823 David JarrossayInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-0924-6395 Federica SallustoInstitute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0003-3750-2752 Gioacchino Natoli *Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-0711-2411 Silvia Monticelli *Institute for Research in Biomedicine, Università della Svizzera italiana , Bellinzona, Switzerland.ORCID 0000-0002-5909-8802 Funding
Ceresio FoundationEuropean Union's Horizon 2020 Research and Innovation Program 733100Horten Health FoundationItalian Ministry of HealthSwiss National Science Foundation 320030_227561
6 · The paper itselfAbstract
Genome-wide association studies investigating autoimmune disorders may reveal previously unrecognized regulators of immune cell functions. A Crohn's disease risk allele was associated with increased expression in T lymphocytes of the adapter protein Src kinase-associated phosphoprotein 2 (SKAP2), whose functional role in these cells is unknown. By analyzing T cells from individuals homozygous for either allelic variant or engineered to modulate SKAP2 endogenous levels, we found that SKAP2 promotes T cell adhesion while restraining migration, acting nonredundantly with its homologue SKAP1. Consistent with such functional differences, SKAP1 and SKAP2 displayed distinct activation-induced regulation as well as unique protein interactomes. Prolonged TCR activation triggered caspase-mediated SKAP2 cleavage, leading to the disassembly of its interactome and enabling a migratory program. Together, these findings identify SKAP2 as a genetically regulated modulator of T cell function whose expression and activity control the balance between adhesion and migration.
Indexed as
Adaptor Proteins, Signal TransducingCell AdhesionCell MovementPhosphoproteinsT-LymphocytesCrohn DiseaseHumansIntracellular Signaling Peptides and ProteinsAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsPhosphoproteinsSKAP1 protein, humansrc kinase associated phosphoprotein 2
Identifiers
PMID42900686
PMCPMC13682646
What OpenQuestion holds
Textmetadata
Read underepoch 390